A conceptual framework for evaluating impairments in myasthenia gravis.
BACKGROUND:Myasthenia gravis is characterized by weakness and fatigability of different muscle groups, including ocular, bulbar and the limbs. Therefore, a measure of disease severity at the impairment level in myasthenia needs to reflect all the relevant impairments, as well as their variations wit...
Main Authors: | Carolina Barnett, Vera Bril, Moira Kapral, Abhaya Kulkarni, Aileen M Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4028305?pdf=render |
Similar Items
-
Novel Treatments in Myasthenia Gravis
by: Deepak Menon, et al.
Published: (2020-06-01) -
Time to achieve a patient acceptable symptom state in myasthenia gravis
by: Rodrigo Martinez-Harms, et al.
Published: (2023-06-01) -
FcRN receptor antagonists in the management of myasthenia gravis
by: Vinaya Bhandari, et al.
Published: (2023-08-01) -
Prospective study of stress, depression and personality in myasthenia gravis relapses
by: Anca Bogdan, et al.
Published: (2020-06-01) -
Seronegative myasthenia gravis.
by: Vincent, A, et al.
Published: (2004)